Persons who have tested positive for herpes simplex virus type 2 (HSV-2) but do not have symptoms or genital lesions still experience virus shedding during subclinical (without clinical manifestations ...

Epidemiological studies suggest that HSV-2 increases the risk of HIV-1 acquisition. 1, 2, 3 In populations with HSV-2 prevalence of 80%, nearly 50% of HIV-1 infections are attributable to an HSV-2 ...

Male circumcision significantly reduced the incidence of human immunodeficiency virus (HIV) infection among men in three clinical trials. We assessed the efficacy of male circumcision for the ...

Ex vivo analysis of these cells allows unbiased characterization of the cellular composition, function, and phenotype of the local T-cell response to HSV-2. In the present study, we obtained cervical ...

WOBURN, Mass. and OXFORD, England, July 8, 2022 /PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced ...

Herpes simplex virus 2 (HSV-2) is a sexually transmitted infection that can cause painful, recurrent lesions in the genital skin and mucosa. HSV-2 initially infects genital epithelial cells before ...

System from Quest Diagnostics’ products business is first FDA-cleared Herpes Simplex Virus 1 and 2 test that uses genital swab or cerebrospinal fluid (CSF) specimen collection Quest Diagnostics (NYSE: ...

Asymptomatic herpes simplex virus type 2 (HSV-2) infection is well described, but its natural history and relative transmissibility remain unclear. In this prospective study, researchers evaluated the ...

Vaccines are one of the most important medical inventions of modern times that have saved and enhanced innumerable lives around the world. Despite the technological advances in vaccine design and ...

As per the data released by the World Health Organisation (WHO), 3.7 billion people globally have herpes simplex virus type 1 (HSV 1) and 491 million have herpes simplex virus type 2 (HSV-2) infection ...

Serum YKL-40 levels in patients with cervical cancer are elevated compared to patients with cervical intraepithelial neoplasia and healthy controls No significant financial relationships to disclose.

Assembly Biosciences Inc. has selected development candidate ABI-5366 to progress to IND-enabling studies from its long-acting herpes simplex virus type 2 (HSV-2) helicase inhibitor program for ...